David Tougeron
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 92
- Cancer Immunotherapy and Biomarkers 33
- Pancreatic and Hepatic Oncology Research 23
- Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment 19
-
- Genetic factors in colorectal cancer 60
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 28
-
- Gastric Cancer Management and Outcomes 60
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 18
- Co-authors
- Julien Taı̈ebGaëlle TachonFrank A. SinicropeRomain CohenCamille EvrardPierre MichelLucie Karayan‐TaponThierry Lecomte
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
David Tougeron
201 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 2.4k
- Gastroenterology 384
- Pathology and Forensic Medicine 1.0k
- Cancer Research 690
- Pulmonary and Respiratory Medicine 1.4k
Countries citing papers authored by David Tougeron
This map shows the geographic impact of David Tougeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tougeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tougeron more than expected).
Fields of papers citing papers by David Tougeron
This network shows the impact of papers produced by David Tougeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tougeron. The network helps show where David Tougeron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Tougeron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 7 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 7 | |
| 13 | Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Studybreakdown → | 2022 | 220 |
| 14 | 2022 | 6 | |
| 15 | 2022 | 13 | |
| 16 | 2022 | 5 | |
| 17 | 2020 | 19 | |
| 18 | 2019 | 70 | |
| 19 | 2018 | 24 | |
| 20 | 2015 | 24 |
About David Tougeron
David Tougeron is a scholar working on Oncology, Gastroenterology and Pathology and Forensic Medicine, having authored 223 papers that have together received 3.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (92 papers), Gastric Cancer Management and Outcomes (60 papers), Genetic factors in colorectal cancer (60 papers), Cancer Immunotherapy and Biomarkers (33 papers), Cancer Genomics and Diagnostics (28 papers), Pancreatic and Hepatic Oncology Research (23 papers), Gastrointestinal Tumor Research and Treatment (19 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers). The work is most often cited by research in Oncology (2.4k citations), Gastroenterology (384 citations) and Pathology and Forensic Medicine (1.0k citations). David Tougeron has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Julien Taı̈eb, Gaëlle Tachon, Frank A. Sinicrope, Romain Cohen, Camille Evrard, Pierre Michel, Lucie Karayan‐Tapon, Thierry Lecomte, Violaine Randrian and Jean–Marc Phelip. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.